The Ann Kolker Advocacy fellowship commemorates the legacy of Ann Kolker, a pioneering health policy advocate and a founder of Ovarian Cancer National Alliance, which later became Ovarian Cancer Research Alliance. Ann passed on February 3, 2016, after her long and courageous battle with ovarian cancer, leaving behind her husband, 3 kids, and numerous grandchildren. … Continued
OCRA’s Advocate Leader committees gathered last week to strategize and mobilize for impactful change. Each committee aims to make strides in specific areas of focus. Our committees will continue to convene throughout the year to tackle specific challenges and opportunities in our fight against ovarian and related gynecologic cancers. Other legislative activities that have been … Continued
It was a busy and exciting month for OCRA’s policy team and advocates from all across the country. OCRA’s 2024 Spring Advocacy Day took place on March 20, during which 140 advocates met with their Members of Congress and urged them to support increased funding for education and research programs focused on ovarian and related … Continued
OCRA’s Advocates are off to a running start this year with help from our largest Advocate Leader cohort in program history, at 125 participants representing 39 states and 111 congressional districts. Together with the OCRA policy team, Advocate Leaders are working to advance crucial legislative goals, including expanding federal funding of ovarian and other gynecologic cancer … Continued
Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic cancer community. OCRA’s Advocates are beginning 2024 with great momentum. Here’s a look at our most impactful achievements in 2023: As the largest organization advocating … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
